Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous versus intramuscular testosterone undecanoate in men with hypogonadism
ACTRN12613000101785Phase 4Completed
- Sponsor
- Sydney Local Health District
- Start
- Feb 2014
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of testosterone undecanoate in Hypoandrogenism (TD) (2 arms), sponsored by Sydney Local Health District. Primary endpoint: Time profile of serum testosterone concentrations. Started Feb 2014; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on ACTRN12613000101785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000101785.